Alerts will be sent to your verified email
Verify Email
MARKSANS
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Marksans Pharma is an Indian pharmaceutical company with a global presence, excelling in research, manufacturing, and marketing of finished dosage pharmaceutical formulations. Their focus areas include a wide range of OTC & prescription drugs across various fields.
Marksans Pharma major competitors are FDC, Strides Pharma Scien, Procter&Gamble Healt, Sequent Scientific, Guj. Themis Biosyn, Orchid Pharma, Gufic Biosciences.
Market Cap of Marksans Pharma is ₹7,611 Crs.
While the median market cap of its peers are ₹4,263 Crs.
Marksans Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | Mar Jun Sep | Mar Jun Sep | Jun Dec | Jun | Mar | Sep Dec | Jun Sep | |||||||
| Investor Presentation | Feb May Aug | Feb Mar Jun Sep Dec | Mar Jun Sep Dec | Feb Mar May Jun Aug Sep Nov Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | |||||||||||
| Conference Call | Mar Jun | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep | Dec | ||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
